Schedule 13G ownership disclosure

AVADEL PHARMACEUTICALS PLC

Security class unavailable · CUSIP: 05337M104

Event date: 2019-11-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,440,050
Percent of class
11.8600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-070118
Form type
SC 13G/A
Filer
AVADEL PHARMACEUTICALS PLC
CIK
CIK 1012477
Filed
Dec 05, 2019
Reporting period
Nov 29, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub